Inhibition of the promotion of hepatocarcinogenesis by 2,2′,4,4′,5,5′-hexachlorobiphenyl (PCB-153) by the deletion of the p50 subunit of NF-κB in mice
Introduction
Polychlorinated biphenyls (PCBs) were commercially manufactured in the United States from 1930 to 1970 for use as dielectrics in transformers and capacitors, and as cooling fluids in hydraulic systems. PCBs have also been used in the formulation of lubricating and cutting oils, in pesticides and flame retardants, and as plasticizers in paints, copying paper, adhesives, sealants and plastics (World Health Organization, 1976). The stability of these compounds, one of their commercial attributes, has led to their worldwide distribution in the environment, an observation which was first reported by Jensen (1966). The production of PCBs peaked in 1970 and has steadily declined thereafter as many countries throughout the world have banned certain uses or limited their production. Nevertheless these compounds remain in use and in our environment today and represent a potential human health hazard (Robertson and Hansen, 2001).
Although most PCBs are not particularly acutely toxic, their persistence and lipophilicity as well as their propensity to accumulate in fatty tissues raise concerns over their long-term effects. In animals and humans, chronic exposure to PCBs produces a variety of effects including decreased body weight (wasting syndrome), chloracne, edema, liver hypertrophy, porphyria, estrogenic activity, immunosuppression and neurotoxicity (National Research Council, 1979, Robertson and Hansen, 2001). The carcinogenicity of PCBs in humans has been examined in several epidemiological studies, and associations have been noted in some studies between PCB exposure and cancers of the liver, biliary tract, and intestines, as well as malignant melanoma (Faroon et al., 2001). In the Yusho poisoning incident, a statistically significant increase in the mortality from liver cancer wasobserved in males (but not females) exposed to PCBs (Kuratsume et al., 1996).
The evidence to date indicates that mixtures of PCBs can induce preneoplastic lesions and hepatocellular carcinomas in animals when given at appropriate doses for extended periods of time (Silberhorn et al., 1990, Mayes et al., 1998). Although their potency varies, mixtures of halogenated biphenyls as well as many individual congeners have been reported to be promoters of carcinogenesis in various liver tumor models (Glauert et al., 2001). Generally those compounds which are inducers of cytochrome P-450 (such as the higher halogenated biphenyls) were more potent as promoters. This includes PCB congeners that activate the Ah receptor, the constitutive androstane receptor (CAR), and the pregnane X receptor (PXR) (Ludewig et al., 2007).
Although PCBs clearly have promoting activity in the liver, their mechanism of action is not known. A number of mechanisms have been proposed, including direct effects on signal transduction pathways, induction of oxidative stress, effects on vitamin A metabolism, and effects on intercellular communication (Glauert et al., 2001). One mechanism by which PCBs may promote hepatic tumors is by inducing oxidative damage in the liver. Forms of oxidative damage that may be important are the induction of lipid peroxidation, the induction of oxidative DNA damage, and the alteration of gene expression. The majority of studies have found that PCBs increase hepatic lipid peroxidation (Kamohara et al., 1984, Oda et al., 1987, Dogra et al., 1988, Pelissier et al., 1990, Saito, 1990, Fadhel et al., 2002). Certain congeneric PCBs administered for short time periods were found to increase the levels of oxidative DNA damage, using 8-hydroxyguanosine as the endpoint (Oakley et al., 1996).
Nuclear factor-κB (NF-κB) is a eukaryotic transcription factor family consisting of dimers of the following proteins: p50 (NF-κB1), p65 (RelA), p52 (NF-κB2), c-Rel, and RelB. It is normally found in the cytoplasm as an inactive dimer bound to an inhibitory subunit, IκB, which also has several family members, including IκBα, IκBβ, IκBγ, and IκBɛ (Karin and Lin, 2002). Upon activation, NF-κB is released from IκB and translocates to the nucleus, where it increases the transcription of specific genes. There are two main pathways: the classical pathway, in which the p50:p65 heterodimer is predominate; and an alternative pathway, in which the p52:RelB dimer is activated (Senftleben et al., 2001, Karin and Lin, 2002). These processes require the phosphorylation of IκB, followed by the subsequent degradation via an ubiquitin-mediated 26S proteosome pathway (Karin and Lin, 2002). A 900 kDa complex, termed the IκB kinase (IKK) complex has been identified and consists of two kinase subunits of IKK, IKKα and IKKβ, and a regulatory subunit, IKKγ (Zandi et al., 1997, Karin and Delhase, 2000). These two kinase subunits form homo- or hetero-dimers that phosphorylate IκB molecules, leading to their degradation. NF-κB has been shown to be important in the activation of genes that regulate cell proliferation and apoptosis (Beg et al., 1995, Fitzgerald et al., 1995).
Several studies have used genetically modified mice to examine the role of NF-κB subunits on cell proliferation and apoptosis in the liver and other tissues. A clear role for NF-κB in inhibiting apoptosis by TNF-α or other apoptosis inducers has been demonstrated in several cell types, in studies in which NF-κB activity has been inhibited by the deletion of one of its subunits, the inhibition of its translocation, or the expression of a dominant negative form of IκB (Beg and Baltimore, 1996, Vanantwerp et al., 1996, Wang et al., 1996, Xu et al., 1998a, Schoemaker et al., 2002). However, DNA synthesis and liver regeneration were not affected by the absence of the p50 subunit following partial hepatectomy or carbon tetrachloride treatment (Deangelis et al., 2001). Similarly, the hepatic-specific expression of a truncated IκBα super-repressor did not affect DNA synthesis, apoptosis, or liver regeneration following partial hepatectomy, but led to increased apoptosis after treatment with TNF-α (Chaisson et al., 2002). Also, the hepatic inflammatory response after ischemia/reperfusion was not altered in p50−/− mice (Kato et al., 2002). In addition, B cells lacking p50, RelB, or c-Rel (but not p52 or p65) have decreased proliferation in response to LPS (Kontgen et al., 1995, Sha et al., 1995, Snapper et al., 1996a, Snapper et al., 1996b, Horwitz et al., 1999). Overall, whether specific NF-κB subunits are essential for cell proliferation depends on the tissue and the stimulus for DNA synthesis.
One mechanism by which NF-κB may be activated is by increased oxidative stress. NF-κB can be activated in vitro by H2O2, and its activation can be inhibited by antioxidants, such as vitamin E or N-acetyl cysteine (NAC), or by increased expression of antioxidant enzymes (Staal et al., 1990, Schreck et al., 1991, Schreck et al., 1992, Meyer et al., 1993, Nilakantan et al., 1998, Li et al., 2000, Calfee-Mason et al., 2004). In addition, agents that activate NF-κB frequently also increase oxidative stress (Schmidt et al., 1995). However, Hayakawa et al. (2003) found that NAC inhibits NF-κB activation independently of its antioxidant function.
PCBs also can activate NF-κB. PCB-77 was found to activate NF-κB in rats after long-term treatment but not after a single dose (Tharappel et al., 2002, Lu et al., 2003, Glauert et al., 2005). PCB-153, in contrast, was found to activate NF-κB in rats after a single dose (Lu et al., 2003), but only activated NF-κB after multiple doses in one of three studies (Tharappel et al., 2002, Lu et al., 2004, Glauert et al., 2005). We subsequently found that cell proliferation induced by PCB-153 could be inhibited in mice lacking the p50 subunit of NF-κB (p50−/− mice) (Lu et al., 2004).
In this study we have examined if the deletion of the p50 subunit of NF-κB would inhibit the tumor promoting activity of PCB-153. Wild-type and p50−/− mice were first administered diethylnitrosamine (DEN) as a tumor initiator and then were exposed to PCB-153. The induction of hepatic tumors as well as effects on cell proliferation and apoptosis were quantified.
Section snippets
Chemicals
PCB-153 (2,2′,4,4′,5,5′-hexachlorobiphenyl) was synthesized and characterized as described previously; its purity was greater than 99%, as assayed by gas-chromatography (Schramm etal., 1985). Diethylnitrosamine was obtained from Sigma Chemical Co., St. Louis, MO.
Experimental design
Mice homozygous for p50−/− deletion and B6129SF2/J age-matched wild-type controls were obtained from our breeding colony. Founders of this strain had been obtained from The Jackson Laboratory (Bar Harbor, ME). After weaning, mice were
Results
In this study, we examined whether the p50 subunit of NF-κB is necessary for the promoting activities of PCB-153. Following DEN administration, PCB-153 was administered every other week for 20 injections followed by 15 weeks of no further treatment. At the conclusion of the study, body weights were lower in p50−/− mice compared to wild-type mice (in both PCB- and vehicle-treated). PCB-153 administration decreased weight gain in wild-type mice (Table 1); the p50−/− mice not administered PCB-153
Discussion
In this paper we have found that the deletion of the p50 subunit of NF-κB inhibits the tumor promoting activity of PCB-153. Both the tumor incidence and the volume of GS-positive tumors (the main tumor type) were decreased in p50−/− mice. In addition the induction of cell proliferation by PCB-153 in normal hepatocytes was inhibited in p50−/− mice. PCB-153 also slightly increased apoptosis in hepatic tumors in p50−/− mice but not wild-type mice.
Overall the results show that p50 deletion inhibits
Conflict of interest statement
There are no conflicts of interest.
Acknowledgments
We thank Petruta Bunaciu, Jason Lu, Divinia Stemm, Jill Cholewa, and Amy Dugan for their assistance with the project. This study was funded by the National Institutes of Health (ES013661, ES07380, and ES012475) and by the Kentucky Agricultural Experiment Station. The study sponsors had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.
References (73)
- et al.
The effect of dietary glycine on the hepatic tumor promoting activity of polychlorinated biphenyls (PCBs) in rats
Toxicology
(2007) - et al.
Effects of vitamin E on the NF-kB pathway in rats treated with the peroxisome proliferator, ciprofibrate
Toxicol. Appl. Pharmacol.
(2004) - et al.
Normal liver regeneration in p50/nuclear factor kappa B1 knockout mice
Hepatology
(2001) - et al.
Effect of 3,3′,4,4′-tetrachlorobiphenyl and 2,2′,4,4′,5,5′-hexachlorobiphenyl on the induction of hepatic lipid peroxidation and cytochrome P-450 associated enzyme activities in rats
Toxicology
(2002) - et al.
Dietary vitamin E does not inhibit the promotion of liver carcinogenesis by polychlorinated biphenyls in rats
J. Nutr.
(2005) - et al.
Mechanism of lipid peroxide formation in polychlorinated biphenyls (PCB) and dichlorodiphenyltrichloroethane (DDT)-poisoned rats
Environ. Res.
(1984) - et al.
The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling
Semin. Immunol.
(2000) - et al.
Gene deletion of NF-kappa B p50 does not alter the hepatic inflammatory response to ischemia/reperfusion
J. Hepatol.
(2002) - et al.
Activation of nuclear factor-kappa B by the peroxisome proliferator ciprofibrate in H4IIEC3 rat hepatoma cells and its inhibition by the antioxidants N-acetylcysteine and vitamin E
Biochem. Pharmacol.
(2000) - et al.
IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis
Cell
(2005)
Comparative carcinogenicity in Sprague–Dawley rats of the polychlorinated biphenyl mixtures Aroclors 1016, 1242, 1254, and 1260
Toxicol. Sci.
Long-term effects of dietary polychlorinated biphenyl and high level of vitamin E on ascorbic acid and lipid metabolism in rats
J. Nutr.
Polychlorinated biphenyls-induced lipid peroxidation as measured by thiobarbituric acid-reactive substances in liver subcellular fractions of rats
Biochim. Biophys. Acta
The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-kappa B
Chem. Biol.
Cytokine regulation of pro- and anti-apoptotic genes in rat hepatocytes: NF-kappa B-regulated inhibitor of apoptosis protein 2 (CIAP2) prevents apoptosis
J. Hepatol.
Differential regulation of hepatic glutathione transferase and glutathione peroxidase activities in the rat
Biochemical. Pharmacol.
Targeted disruption of the p50subunit of NF-kB leads to multifocal defects in immune responses
Cell
Regulation of cell proliferation, apoptosis, and transcription factor activities during the promotion of liver carcinogenesis by polychlorinated biphenyls
Toxicol. Appl. Pharmacol.
STEREO: a program on a PC-Windows 95 platform for recording and evaluating quantitative stereologic investigations of multistage hepatocarcinogenesis
Comput. Methods Programs Biomed.
The IkB kinase complex (IKK) contains two kinase subunits, IKK-alpha and IKK-beta, necessary for IkB phorphorylation and NF-kB activation
Cell
An essential role for NF-kappa B in preventing TNF-alpha-induced cell death
Science
Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B
Nature
Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology
Biochem. J.
Function of NF-kappa B/Rel binding sites in the major histocompatibility complex class II invariant chain promoter is dependent on cell-specific binding of different NF-kappa B/Rel subunits
Mol. Cell. Biol.
Application of quantitative stereology to the evaluation of enzyme-altered foci in rat liver
Cancer Res.
Application of quantitative stereology to the evaluation of phenotypically heterogeneous enzyme-altered foci in the rat liver
J. Natl. Cancer Inst.
Hepatocyte-specific inhibition of NF-kappa B leads to apoptosis after TNF treatment, but not after partial hepatectomy
J. Clin. Invest.
Long-term effects of commercial and congeneric polychlorinated biphenyls on ethane production and malondialdehyde levels, indicators of in vivo lipid peroxidation
Arch. Toxicol.
Carcinogenic effects of polychlorinated biphenyls
Toxicol. Ind. Health
Rapid DNA binding by nuclear factor kappa B in hepatocytes at the start of liver regeneration
Cell Growth Differ.
Inhibition of hepatocarcinogenesis by the deletion of the p50 subunit of NF-kB in mice administered the peroxisome proliferator Wy-14,643
Toxicol. Sci.
PCBs and Tumor Promotion
Proliferative and Selected Other Lesions in the Liver of Rats, GI-5
Evidence that reactive oxygen species do not mediate NF-kB activation
EMBO J.
The p65 subunit of NF-kappa B is redundant with p50 during B cell proliferative responses, and is required for germline C–H transcription and class switching to IgG3
J. Immunol.
TNF stimulates expression of mouse MHC class I genes by inducing an NF kappa B-like enhancer binding activity which displaces constitutive factors
EMBO J.
Cited by (24)
PCB153 reduces apoptosis in primary cultures of murine pituitary cells through the activation of NF-κB mediated by PI3K/Akt
2021, Molecular and Cellular EndocrinologyCitation Excerpt :In the pituitary, NF-κB activation may play a role in the immune escape and tumour progression as suggested in cellular models as well as histological studies in humans (Chen et al., 2015). PCB153 can activate NF-κB in the liver (Glauert et al., 2008; Tharappel et al., 2002) and adipocytes (Wu et al., 2017). PCB153 has also been previously associated with an increased nuclear localisation of NF-κB in the liver and small intestine in mouse models (Liu et al., 2014; Phillips et al., 2018).
Associations between functional polychlorinated biphenyls in adipose tissues and prognostic biomarkers of breast cancer patients
2020, Environmental ResearchCitation Excerpt :Tumor stage is also considered as an important parameter to predict tumor prognosis for cancer patients (Hayes et al., 2001). Studies have reported that exposure to PCBs mixtures would increase tumor volume in mice since 1986 (Anderson et al., 1986), and Glauert et al. (2008) found that certain PCB congeners promoted hepatoma tumor volume. Our study evaluated tumor stage through tumor size, lymph lode and metastasis status.
NFκB-p50 as a blood based protein marker for early diagnosis and prognosis of head and neck squamous cell carcinoma
2015, Biochemical and Biophysical Research CommunicationsCitation Excerpt :Involvement of p50 in carcinogenesis has previously reported [24] and there is evidence that p50 as a positive regulator of NF-κB on cell proliferation by mediating cyclin D1 expression [18–20]. Another study supports that the growth of prostate and colon cancer cells can be inhibited by inhibition of cyclin D1 expression through targeting p50 and also p65 [25]. So, p50 could be feasible for protein markers of cancer.
Effect of vitamin E on hepatic cell proliferation and apoptosis in mice deficient in the p50 subunit of NF-κB after treatment with phenobarbital
2011, Food and Chemical ToxicologyCitation Excerpt :The tissues were paraffin embedded and sectioned at 5 μm and mounted on 3-aminopropyl-triethylethoxysilane coated glass slides. Tissue sections were used for bromodeoxyuridine (BrdU) immunohistochemical staining or for terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) staining, as described previously (Calfee-Mason et al., 2008; Glauert et al., 2008b). At least 3000 hepatocellular nuclei were counted randomly per slide to quantify labeling indexes for both cell proliferation and apoptosis.